Average Insider

Where insiders trade, we follow

Protagonist Therapeutics, Inc ($PTGX)
Accession: 0001104659-26-113279
Oct 2, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$62.24
Current$140.0678.9% above low, 21.1% below high
52W High$160.81

Filing Information

Accession Number0001104659-26-113279
Form Type4
Filing DateOct 2, 2026
DocumentView SEC Filing
Transactions
10
Total Shares
175,887
Total Value
$9,703,028.59

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Exercise/Conversion9,229$38.98$359,746.4268,232Directโ€”View Details
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Exercise/Conversion28,438$23.42$666,017.9696,670Directโ€”View Details
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Exercise/Conversion15,650$19.19$300,323.50112,320Directโ€”View Details
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Exercise/Conversion5,312$12.17$64,647.04117,632Directโ€”View Details
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Sale12,595$141.77$1,785,593.15105,037Directโ€”View Details
Ali Asif
Chief Financial Officer
Common Stock
โ€”Sep 30, 2026Sale46,034$141.78$6,526,700.5259,003Directโ€”View Details
Ali Asif
Chief Financial Officer
Stock Option (right to buy)
(Common Stock)
DerivativeSep 30, 2026Exercise/Conversion9,229$0.00$0.0029,291Directโ€”View Details
Ali Asif
Chief Financial Officer
Stock Option (right to buy)
(Common Stock)
DerivativeSep 30, 2026Exercise/Conversion28,438$0.00$0.0049,562Directโ€”View Details
Ali Asif
Chief Financial Officer
Stock Option (right to buy)
(Common Stock)
DerivativeSep 30, 2026Exercise/Conversion15,650$0.00$0.0051,150Directโ€”View Details
Ali Asif
Chief Financial Officer
Stock Option (right to buy)
(Common Stock)
DerivativeSep 30, 2026Exercise/Conversion5,312$0.00$0.0025,235Directโ€”View Details
Version: v26.10.1